


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+2.96%
+1.05%
+1.52%
+1.40%
+7.61%
KVUE
Kenvue
$17.35
Strengths

Trading below its fair value

Investors confidence is positive

Pays a reliable dividend
Risk Analysis

Earnings are forecast to decrease
Technical Indicators

5+ Days Up
KVUE Price Performance
$14.37 (+20.74%)
$20.54 (-15.53%)
$20.76 (-16.43%)
$22.22 (-21.92%)
KVUE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Hit 52-week low

KVUE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Eps growth
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive

Pays a reliable dividend
Future
Future

Earnings are forecast to decrease

Trading below its fair value
![]()
KVUE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
KVUE Street Sentiment is unimpressive and have negative views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is KVUE current stock price?
What are KVUE stock strengths?
What is KVUE Risk Level?
What is KVUE market cap and volume?
What is KVUE current Stock IQ?
Should I buy KVUE stock right now?
Is KVUE a Strong Buy right now?
What does a 'Strong Buy' rating mean for KVUE?
What does a 'Strong Sell' rating mean for KVUE?
What factors influence KVUE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+2.96%
+1.05%
+1.52%
+1.40%
+7.61%
KVUE
Kenvue
Current Price
$17.35
Stock Insights
Strengths

Trading below its fair value

Investors confidence is positive

Pays a reliable dividend
Risk Analysis

Earnings are forecast to decrease
Technical Indicators

5+ Days Up

KVUE Price Performance
$14.37 (+20.74%)
$20.54 (-15.53%)
$20.76 (-16.43%)
$22.22 (-21.92%)
KVUE Analysts Opinion
KVUE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates

Reported a strong earnings

Eps growth
Rating
Rating
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Investors confidence is positive

Pays a reliable dividend
Future
Future

Earnings are forecast to decrease

Trading below its fair value
![]()
KVUE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
KVUE Street Sentiment is unimpressive and have negative views on the near-term outlook
KVUE has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Hit 52-week low

Average key support and resistance price levels
KVUE Stock IQ
KVUE Latest Analysis
SCCM Value Equity Fund Sold Kenvue (KVUE) Due to Less Compelling Valuation.
Thu Nov 20, 2025
Court Rejects Bid To Block Kenvues $398 Million Shareholder Payout In Tylenol Safety Dispute. On Friday a Texas judge declined to halt an upcoming shareholder payout by Texas Attorney General ) handling and marketing of Tylenol amid ongoing litigation over the product'.s .The ruling allows In October Paxton filed a lawsuit against ) and Kenvue accusing the companies of misleading pregnant women about the safety of Tylenol despite evidence suggesting its active ingredient acetaminophen may in
Mon Nov 17, 2025
Barclays Maintains Kenvue (KVUE) Equal-Weight Recommendation. Fintel reports that on November 10 2025 Barclays maintained coverage of Kenvue (NYSE:KVUE) with a Equal-Weight recommendation. Analyst Price Forecast Suggests 23.72% Upside
Tue Nov 11, 2025
Ex-Dividend Reminder: Kenvue Winmark and Rush Enterprises . Looking at the universe of stocks we cover at Dividend Channel on 11/12/25 Kenvue Inc (Symbol: KVUE) Winmark Corp (Symbol: WINA) and Rush Enterprises Inc. (Symbol: RUSHA) will all trade ex-dividend for their respective upcoming dividends. Kenvue Inc will pay its quarterly di
Mon Nov 10, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
KVUE Stock trends
KVUE Stock performance
KVUE Stock analysis
KVUE investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.